|
Docusign Envelope ID:430DA8ED-F2BF-4131-BE14-A60F4552B467
<br /> B. In general, no publication (including websites, reports,projects, etc.) may convey
<br /> System Agency's recognition or endorsement of the Grantee's project without prior
<br /> written approval from System Agency. Publications funded in part or wholly by HHS
<br /> grant funding must include a statement that"HHS and neither any of its components
<br /> operate, control, are responsible for, or necessarily endorse, this publication (including,
<br /> without limitation, its content, technical infrastructure, and policies, and any services or
<br /> tools provided)" at HHS's request.
<br /> 11.17 MEDIA RELEASES
<br /> A. Grantee shall not use System Agency's name, logo, or other likeness in any press
<br /> release, marketing material or other announcement without System Agency's prior
<br /> written approval. System Agency does not endorse any vendor,commodity, or service.
<br /> Grantee is not authorized to make or participate in any media releases or public
<br /> announcements pertaining to this Grant Agreement or the Services to which they relate
<br /> without System Agency's prior written consent, and then only in accordance with
<br /> explicit written instruction from System Agency.
<br /> B. Grantee may publish, at its sole expense, results of Grantee performance under the Grant
<br /> Agreement with the System Agency's prior review and approval, which the System
<br /> Agency may exercise at its sole discretion. Any publication (written, visual, or sound)
<br /> will acknowledge the support received from the System Agency and any Federal agency,
<br /> as appropriate.
<br /> 11.18 PROHIBITION ON NON-COMPETE RESTRICTIONS
<br /> Grantee shall not require any employees or Subcontractors to agree to any conditions, such
<br /> as non-compete clauses or other contractual arrangements, that would limit or restrict such
<br /> persons or entities from employment or contracting with the State of Texas.
<br /> 11.19 SOVEREIGN IMMUNITY
<br /> Nothing in the Grant Agreement will be construed as a waiver of the System Agency's or
<br /> the State's sovereign immunity. This Grant Agreement shall not constitute or be construed as
<br /> a waiver of any of the privileges, rights, defenses, remedies, or immunities available to the
<br /> System Agency or the State of Texas. The failure to enforce, or any delay in the enforcement,
<br /> of any privileges, rights, defenses, remedies, or immunities available to the System Agency
<br /> or the State of Texas under the Grant Agreement or under applicable law shall not constitute
<br /> a waiver of such privileges, rights, defenses, remedies, or immunities or be considered as a
<br /> basis for estoppel. System Agency does not waive any privileges, rights, defenses, or
<br /> immunities available to System Agency by entering into the Grant Agreement or by its
<br /> conduct prior to or subsequent to entering into the Grant Agreement.
<br /> 11.20 ENTIRE CONTRACT AND MODIFICATION
<br /> The Grant Agreement constitutes the entire agreement of the Parties and is intended as a
<br /> complete and exclusive statement of the promises,representations,negotiations,discussions,
<br /> and other agreements that may have been made in connection with the subject matter hereof.
<br /> Any additional or conflicting terms in any future document incorporated into the Grant
<br /> Agreement will be harmonized with this Grant Agreement to the extent possible.
<br /> 11.21 COUNTERPARTS
<br /> This Grant Agreement may be executed in any number of counterparts, each of which will
<br /> be an original, and all such counterparts will together constitute but one and the same Grant
<br /> Agreement.
<br /> HHS Uniform Terms and Conditions—Grant v 3.5
<br /> Effective September 2024
<br /> Page 25 of 27
<br />
|